Literature DB >> 21131808

Chickenpox is not always benign: postvaricella purpura fulminans requires prompt and aggressive treatment.

Simon Fluri1, Gregor W Kaczala, Kurt Leibundgut, Lorenzo Alberio.   

Abstract

We present 2 patients, who were admitted owing to rapidly progressing purpuric lesions due to postvaricella purpura fulminans, a coagulopathy leading to life- or limb-threatening thrombosis caused by a severe transient autoimmune protein S deficiency. Laboratory results were being consistent with disseminated intravascular coagulation secondary to protein S deficiency; treatment with fresh frozen plasma, intravenous immunoglobulins, and prednisone was started. In our experience, a prompt therapy may limit the course and the extent of the disease. We present a review of the topic with supporting literature for the therapeutic options. Therefore, we should be reminded that purpura fulminans is a rare but severe complication of chickenpox, which demands quick action.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21131808     DOI: 10.1097/PEC.0b013e3181fe91cd

Source DB:  PubMed          Journal:  Pediatr Emerg Care        ISSN: 0749-5161            Impact factor:   1.454


  4 in total

1.  [Sepsis-associated Purpura Fulminans International Registry--Europe (SAPFIRE)].

Authors:  F M Brunkhorst; V Patchev
Journal:  Med Klin Intensivmed Notfmed       Date:  2014-10-29       Impact factor: 0.840

2.  Purpura fulminans in a patient with mixed connective tissue disease.

Authors:  Aizuri A Murad; Michael Jeffers; Anne-Marie Tobin; Maureen Connolly
Journal:  BMJ Case Rep       Date:  2013-01-30

3.  Secondary infection of preaxial polydactyly following varicella infection.

Authors:  Ganesh Singh Dharmshaktu; Tanuja Pangtey
Journal:  Ann Afr Med       Date:  2018 Apr-Jun

4.  Idiopathic purpura fulminans associated with anti-protein S antibodies in children: a multicenter case series and systematic review.

Authors:  Alexandre Theron; Olivier Dautremay; Elodie Boissier; Amel Zerroukhi; Julien Baleine; Lionel Moulis; Michel Rodière; Jean-François Schved; Martha Duraes; Tarik Kanouni; Isabelle Cau-Diaz; Eric Jeziorski; Christine Biron-Andreani
Journal:  Blood Adv       Date:  2022-01-25
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.